title: [STRATEGY OF ANTIBACTERIAL THERAPY IN PATIENTS WITH SEPSIS. Part 2].
authors.forename: S D
authors.initials: SD
authors.lastname: Shapoval
authors.forename: I L
authors.initials: IL
authors.lastname: Savon
authors.forename: V B
authors.initials: VB
authors.lastname: Martynyuk
authors.forename: L A
authors.initials: LA
authors.lastname: Vasylevska
authors.forename: A M
authors.initials: AM
authors.lastname: Yakunych
authors.forename: O O
authors.initials: OO
authors.lastname: Maksymova
authors.forename: M M
authors.initials: MM
authors.lastname: Sofilkanych
mesh_terms: D000900:Anti-Bacterial Agents / Q000145:classification / Q000627:therapeutic use*; D000935:Antifungal Agents / Q000627:therapeutic use*; D004333:Drug Administration Routes; D004334:Drug Administration Schedule; D024901:Drug Resistance, Multiple, Bacterial; D026141:Drug Resistance, Multiple, Fungal; D004359:Drug Therapy, Combination; D016905:Gram-Negative Bacterial Infections / Q000188:drug therapy* / Q000382:microbiology / Q000473:pathology; D016908:Gram-Positive Bacterial Infections / Q000188:drug therapy* / Q000382:microbiology / Q000473:pathology; D006801:Humans; D009181:Mycoses / Q000188:drug therapy* / Q000382:microbiology / Q000473:pathology; D018805:Sepsis / Q000188:drug therapy* / Q000382:microbiology / Q000473:pathology
chemical_list: D000900:Anti-Bacterial Agents; D000935:Antifungal Agents